NASDAQ:MRKR

Marker Therapeutics Stock Forecast

etoro logo Buy MRKR
*Your capital is at risk
$0.95
+0.0318 (+3.45%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of MRKR
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Green day on Monday for Marker Therapeutics Inc.
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 03, 2025 Loss -0.48%

The Marker Therapeutics Inc. stock price gained 3.45% on the last trading day (Monday, 17th Nov 2025), rising from $0.92 to $0.95. During the last trading day the stock fluctuated 9.64% from a day low at $0.93 to a day high of $1.02. The price has been going up and down for this period, and there has been a -0.48% loss for the last 2 weeks. Volume fell on the last day by -24 thousand shares and in total, 198 thousand shares were bought and sold for approximately $189.20 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.06% during the next 3 months and, with a 90% probability hold a price between $0.734 and $0.97 at the end of this 3-month period.

MRKR Signals & Forecast

There are few to no technical positive signals at the moment. The Marker Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.98. On a fall, the stock will find some support from the short-term average at $0.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, October 08, 2025, and so far it has fallen -11.59%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Marker Therapeutics Inc. stock

Marker Therapeutics Inc. finds support from accumulated volume at $0.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0897 between high and low, or 9.64%. For the last week the stock has had daily average volatility of 7.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MRKR) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Marker Therapeutics Inc. to open at $0.97, and during the day (based on 14 day Average True Range), to move between $0.92 and $0.99, which gives a possible trading interval of +/-$0.0628 (+/-6.80%) up or down from last closing price. If Marker Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.94 (1.56%) than the resistance at $1.00 (4.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Marker Therapeutics Inc. stock A Buy?

Marker Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.982 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.97 ( 1.42%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

MRKR Performance

Trading levels for MRKR

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.06 10.82%
R2 1.02 7.23%
R1 1.00 5.01%
Price 0.95
S1 0.93 -2.17%
S2 0.91 -4.38%
S3 0.88 -7.97%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.08 13.11%
R2 1.06 11.02%
R1 1.00 4.73%
Price 0.95
S1 0.94 -1.56%
S2 0.93 -3.05%
S3 0.90 -6.15%

FAQ

What is the symbol for Marker Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Marker Therapeutics Inc. is MRKR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Marker Therapeutics Inc. Stock?
Marker Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Marker Therapeutics Inc. Stock?
Marker Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Marker Therapeutics Inc. Stock.

What's the current price of Marker Therapeutics Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Marker Therapeutics Inc. (MRKR) share was $0.95.

What is the 52-week high and low for Marker Therapeutics Inc. Stock?
The 52-week high for Marker Therapeutics Inc. Stock is $5.95 and the 52-week low is $0.81.

What is the market capitalization of Marker Therapeutics Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Marker Therapeutics Inc. is 10.31M.

When is the next earnings date for Marker Therapeutics Inc.?
The upcoming earnings date for Marker Therapeutics Inc. is Mar 30, 2026.
Click to get the best stock tips daily for free!
ABOUT MARKER THERAPEUTICS INC.
Marker Therapeutics
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE